Time trends in incidence and prognosis of primary liver cancer and liver metastases of unknown origin in a Danish region, 1985-2004

European Journal of Gastroenterology & Hepatology
Rune ErichsenHenrik T Sørensen

Abstract

Changes, over the last 20 years, in the diagnostic procedures and treatment of primary liver cancer (PLC) and liver metastases of unknown origin (LMUO) may have affected the clinical course of both cancers. Few longitudinal studies examined this issue. In a population-based setting, we studied changes in the incidence and prognosis of PLC and LMUO over time. Between 1985 and 2004, we identified 2675 patients with PLC and LMUO in three Danish counties, with a population of 1.4 million. We computed the standardized incidence rate (SIR), ratio of PLC to LMUO diagnoses, median survival, and estimated mortality rate ratio adjusted for age, sex, and comorbidity. The SIR of PLC increased from 3.2 in 1985 to 5.0 in 2003, and the SIR of LMUO increased from 3.7 to 6.4. No increase was noted in the PLC-to-LMUO ratio over time (P=0.1 for trend). From 1985 to 2004, the median survival of PLC patients increased from 1.6 to 2.9 months whereas that of LMUO patients decreased from 1.7 to 1.3 months. Adjusting for age, sex, and comorbidity did not affect the mortality rate ratio estimates. The incidence of both PLC and LMUO increased over time, whereas the PLC-to-LMUO ratio remained unchanged. Median survival of PLC patients has increased wherea...Continue Reading

References

Apr 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T P Almdal, T I Sørensen
Jun 26, 1997·The New England Journal of Medicine·S Saini
Jul 17, 1998·Transplant International : Official Journal of the European Society for Organ Transplantation·G ColellaD Forti
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FaivreM Sant
Apr 29, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C La VecchiaF Levi
Apr 27, 2001·Journal of Hepatology·S GaianiL Bolondi
Oct 31, 2001·Seminars in Oncology·F V Coakley, L H Schwartz
Nov 17, 2001·European Journal of Gastroenterology & Hepatology·F FarinatiR Naccarato
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A J van de WouwH F P Hillen
May 23, 2002·Gastroenterology·Alex S Befeler, Adrian M Di Bisceglie
Aug 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviC La Vecchia
Nov 26, 2002·Journal of Hepatology·Shahid A KhanHoward C Thomas
Jan 11, 2003·European Radiology·Christopher J HarveyDavid O Cosgrove
Apr 8, 2004·International Journal of Cancer. Journal International Du Cancer·Fabio LeviCarlo La Vecchia
Aug 19, 2004·European Journal of Gastroenterology & Hepatology·Josepa RibesF Xavier Bosch
Oct 22, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Angelo AndriulliFrancesco Perri
Oct 28, 2004·Gastroenterology·F Xavier BoschRamon Cléries
Mar 11, 2005·Best Practice & Research. Clinical Gastroenterology·Morris Sherman
Apr 14, 2005·European Journal of Gastroenterology & Hepatology·Josep M Llovet, Margarita Sala
May 27, 2005·Seminars in Liver Disease·Morris Sherman
Nov 11, 2005·The American Journal of Gastroenterology·Thomas ZoepfJürgen F Riemann
Mar 7, 2006·Gastroentérologie Clinique Et Biologique·Damien PouesselMarc Ychou
Aug 12, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Naota TauraKatsumi Eguchi
Jun 9, 2007·International Journal of Cancer. Journal International Du Cancer·Peter JepsenHenrik Toft Sørensen

❮ Previous
Next ❯

Citations

Aug 5, 2011·Clinical Epidemiology·Jonathan MontomoliJacob Bonde Jacobsen
Apr 11, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yi ZhangSen-Lin Zhu
Feb 22, 2012·Biochemical Pharmacology·Chris Zhiyi ZhangPaul Bo San Lai
Feb 20, 2013·Journal of Hepatology·Martin BlachierFrançoise Roudot-Thoraval

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved